China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 55   

Articles published

CBPO 36.74 +0.21 (0.57%)
price chart
Get Quote Search Site
China Biologic Products, Inc. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of China Biologic Products, Inc. By Business Wire, Investor's Business ...
Related articles »  
China Biologic Announces Favorable Resolution to Title Dispute Involving ...
BEIJING, April 2, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has learned that ...
Related articles »  
China Biologic Announces Receiving GMP Certification at its Guizhou Taibang ...
BEIJING, March 19, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has received ...
Related articles »  
Biotech Losers: China Biologic Products (NASDAQ:CBPO), Heat Biologics ...
China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its financial results for the fourth quarter and fiscal year 2013.
Healthcare Gainers: Fate Therapeutics (NASDAQ:FATE), China Biologic ...
China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China , announced its financial results for the fourth quarter and fiscal year 2013.
Related articles »  
China Biologic Products Upgraded to "Buy" by Aegis (CBPO)
China Biologic Products, Inc is a biopharmaceutical company and through its Chinese subsidiaries, Shandong Taibang and Qianfeng, and Huitian, the Company is engaged in the research, development and manufacturing of plasma-based pharmaceutical ...
Cardium Therapeutics Inc.: Taxus Cardium Presents Year-End 2013 Financial ...
Excellagen� is an FDA-cleared, pharmaceutically-formulated acellular biological modulator that has been engineered to activate and promote wound healing through the growth of granulation tissue in chronic non-healing diabetic foot, pressure and venous ...
Techne Corporation: Bio-Techne Announces Acquisition Agreement
R&D Systems, a member of the Bio-Techne group, is a leading developer and manufacturer of purified cytokines (proteins), antibodies, immunoassays and biologically active small molecules, which are sold to biomedical researchers and clinical research ...
WuXi PharmaTech Announces Management Appointments
SHANGHAI, April 15, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that Dr. Steve Yang has ...
Bio-Techne Announces Acquisition Agreement
R&D Systems, a member of the Bio-Techne group, is a leading developer and manufacturer of purified cytokines (proteins), antibodies, immunoassays and biologically active small molecules, which are sold to biomedical researchers and clinical research ...